Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009

Journal of Infectious Diseases

Volumn 208, Issue 11, 2013, Pages 1859-1868

  Weinmann, Sheila ^a   Chun, Colleen ^a,b   Schmid, D Scott ^c   Roberts, Michelle ^a   Vandermeer, Meredith ^a   Riedlinger, Karen ^a   Bialek, Stephanie R ^c   Marin, Mona ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b Department of Pediatrics ^*  (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Children; Epidemiology; Herpes zoster; Incidence; Shingles; Varicella vaccine; Varicella zoster virus

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOME; ELECTRONIC MEDICAL RECORD; FEMALE; HERPES ZOSTER; HUMAN; HYPERSENSITIVITY; INCIDENCE; INFANT; MALE; PAIN; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; SCHOOL CHILD; SKIN DEFECT; SKIN TINGLING; VACCINATION; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VIRUS IDENTIFICATION;

CHILDREN; EPIDEMIOLOGY; HERPES ZOSTER; INCIDENCE; SHINGLES; VARICELLA VACCINE; VARICELLA ZOSTER VIRUS;

ADOLESCENT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; ELECTRONIC HEALTH RECORDS; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; MALE; OREGON; PREDICTIVE VALUE OF TESTS; VACCINATION; WASHINGTON;

EID: 84888610551     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit405     Document Type: Article

References (24)

1. Petursson G, Helgason S, Gudmundsson S, Sigurdsson JA. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998; 17:905-8.
2. Whitley RJ. Varicella-zoster virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice on infectious diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier, 2011:1963-70.
3. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis 2008; 197:71-5.
4. Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28:954-9.
5. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 1991; 325:1545-50.
6. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev 2010; 23:202-17.
7. Chun C, Weinmann S, Riedlinger K, et al. Laboratory characteristics of suspected herpes zoster in vaccinated children. Pediatr Infect Dis J 2011; 30:719-21.
8. Takayama N, Yamada H, Kaku H, Minamitani M. Herpes zoster in immunocompetent and immunocompromised Japanese children. Pediatr Int 2000; 42:275-9.
9. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA 2000; 284:1271-9.
10. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19:916-23.
11. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol 2000; 38:4315-9.
12. Agresti A. Categorical data analysis. 2nd ed. Hoboken: John Wiley & Sons, 2002:734.
13. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005; 133:245-53.
14. Rothman KJ, Greenland SG. Modern epidemiology. 2nd ed. Boston, MA: Little, Brown, and Co, 1992.
15. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191:2002-2007.
16. Son M, Shapiro ED, LaRussa P, et al. Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 2010; 201:1806-10.
17. Gershon AA, Mervish N, La Russa P, et al. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect Dis 1997; 176:1496-500.
18. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155:1605-9.
19. Guess HA, Broughton DD, Melton LJ, Kurland LT. Populationbased studies of varicella complications. Pediatrics 1986; 78:723-7.
20. Guess HA, Broughton DD, Melton LJ, Kurland LT. Epidemiology of herpes zoster in children and adolescents: A population-based study. Pediatrics 1985; 76:512-7.
21. Chidiac C, Bruxelle J, Daures J-P, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62-69.
22. Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 1965; 58:9-20.
23. Baba K, Yabuuchi H, Takahashi M, Orgra PL. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J. Pediatr 1986; 108:372-7.
24. Gershon AA, Chen J, Davis L, et al. Latency of varicella virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc 2012; 123:17-35.